Physician profile
Keith E Segall
NPI 1639245368
$348.02
in general payments reported to CMS, 2019-2025
9 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.34 · 2023: $32.32 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.94 | 2025 | |
| Dexcom, INC. | $68.32 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $27.38 | 2019 | |
| Insulet Corporation | $22.79 | 2025 | Omnipod |
| Organon LLC | $20.53 | 2025 | Nexplanon |
| Pfizer INC. | $17.96 | 2019 | |
| Novo Nordisk INC | $17.78 | 2025 | Rybelsus, Ozempic |
| Otsuka America Pharmaceutical, INC. | $16.88 | 2023 | Abilify Maintena, Rexulti |
| Teva Pharmaceuticals USA, INC. | $15.44 | 2023 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Segall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.